https://www.selleckchem.com/pr....oducts/ver155008.htm
The progressive myoclonus epilepsy (PME) is a rare group of clinically and genetically heterogeneous disorders characterized by myoclonus, drug refractory epilepsy, and neurological deterioration. Here, we report a three-year-old female patient with neuroregression after a period of normal development and uncontrollable myoclonic seizures, which fulfill the criteria of PME. Next-generation sequencing revealed a novel homozygous mutation of variant c.173GC in exon 2 of the KCDT7 (potassium channel tetramerization domain containing
Like
Comment
Share
